top of page

Cardiovascular diseases are irreversible. So, it is crucial to prevent them before they appear

Order your kit today and find out if you are developing a cardiovascular disease before it is too late. 

How we do it

Why we do it 

Who is it for

ABOUT US

SPINOVIT is a spin-off of UCLouvain funded by Vives, B2start and SRIW.

The product and service were developed in the laboratory of Prof. Jean-Luc Balligand, Institute of Experimental and Clinical Research. 

The Project Beta3_LVH funded by the European Union (Horizon 2020), a clinical trial aiming the prevention of heart failure, sustained the developement of this spin-off through the collection of samples in 9 european countries, allowing us to validate the concept developed in SPINOVIT. 

The Walloon Region supported the creation of the spin-off with a First Spin-Off grant and the proof of concept through the clinical trial PICA, demonstrating the predicability of our biomarker. 

UCLouvain IREC.jpg
Vives.jpg
InvestBW.png
SRIW.png
PICA logo final.png
About
Our team

THE TEAM

2016_irec_vanoverstraeten_001_edited.jpg

Nancy Van Overstraeten

Founder &

Managing Director

2016_irec_balligand_002_edited.jpg

Jean-Luc Balligand

Scientific Advisory Board

22_04_03_spinovit_016_edited.jpg

Arvind

Soni

EPR operator

Jerome Linden_4.jpg

Jérôme 

Linden

Clinical Trial Manager

22_04_03_spinovit_011.jpg

Nathalie Fabian

EPR technician

Testimonials

TESTIMONIALS

"Finally, something to prevent the cardiovascular diseases"

Guy S.

"Security is just 1 mL of blood away."

Jeanine R.

"I feel safe again"

Albert V.

Contact

CONTACT

SPINOVIT.jpg

Administration:

SPINOVIT SRL

6, rue Louis de Geer

1348 Louvain-La-Neuve

Belgium

BE 078 078 4375

 

Lab:

57, avenue Hippocrate

1200 Bruxelles

Belgium

Tel: 32 (02) 7645288

Mobile: 32 (477) 134883

contact@spinovit.com

  • Instagram
  • Facebook
bottom of page